新发虫媒病毒血清学诊断的挑战
本文系统综述了新发虫媒病毒(包括寨卡、登革和基孔肯雅病毒)血清学检测面临的挑战。基于89篇同行评议文章的数据,分析了商用抗体和抗原检测方法的性能,讨论了检测时机、配对样本、既往感染史和交叉反应对抗体检测的影响。快速检测在床旁环境中灵敏度显著低于实验室ELISA,检测性能在流行区和非流行区差异很大。
要点
- 血清学检测需考虑采血时机,急性期和恢复期配对样本可优化灵敏度和特异性。
- 既往虫媒病毒及其他病原体感染史可导致交叉反应和「原始抗原罪」,影响结果准确性。
- 快速床旁抗体/抗原检测灵敏度显著低于实验室ELISA,需根据患病率和用途权衡灵敏度与特异性。
核心结论
- 可靠的血清学诊断需认识检测固有局限性,多重检测和恢复期样本可改善性能,但明确结果并非总能获得。
研究设计与样本
- 系统文献检索PubMed,从89篇同行评议文章中提取商用抗体和抗原检测性能数据集。
主要发现
- 快速床旁抗体和抗原检测的灵敏度显著低于实验室ELISA等检测。
- 抗体和抗原检测的性能在热带流行区与非流行区之间差异很大。
- 个体感染史(不同虫媒病毒、疱疹病毒、疟原虫)可导致血清学检测结果不准确。
- 检测时机及急性期与恢复期配对样本对优化灵敏度和特异性至关重要。
临床怎么用
- 应结合疾病患病率和检测预期用途,仔细权衡并优先考虑灵敏度或特异性。
- 需了解检测固有局限性,对(再)发病毒全球传播需仔细实施和评估血清学检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Appropriate laboratory diagnostics for emerging arboviruses are key for patient management, surveillance and intervention, including molecular tests and serological tests detecting viral antigen or virus-specific antibodies. OBJECTIVES: We provide an overview of the challenges towards serological testing for the most important emerging arboviruses, including Zika, dengue and chikungunya viruses. SOURCES: We retrieved a data set on performance of commercially available antibody- and antigen-detecting tests from 89 peer-reviewed articles conducting a systematic literature research in PubMed. CONTENT: We identified commonly used antibody- and antigen-detecting tests and analysed their overall performance. We discuss how timing of serological testing and the use of paired samples from acute and convalescent phases of infection are crucial to optimize diagnostic sensitivity and specificity. We then exemplify how serological diagnostics are challenged by the patient's infection history through the 'original antigenic sin' and cross-reactive antibodies in the context of global co-circulation of antigenically related viruses. We highlight how individual infection histories with different arboviruses and with other pathogens such as herpes viruses and Plasmodia can produce inaccurate test results. We show that rapid tests for antibody and antigen detection in point-of-care settings have a significantly lower sensitivity compared with laboratory-based tests such as ELISA. We show that the performance of antibody- and antigen-detecting tests varies greatly between tropical regions of endemic transmission and non-endemic regions. Finally, we highlight that test sensitivity and specificity have to be equilibrated carefully and frequently either of them must be prioritized over the other, depending on disease prevalence and intended use of tests. IMPLICATIONS: For reliable serological diagnostics, it is essential to be aware of inherent test limitations. Although multiplexed testing and testing of convalescence samples can improve diagnostic performance, global spread of (re-)emerging viruses requires careful implementation and evaluation of serological testing and unambiguous results may not always be achievable.
引用
- Fischer C, Jo WK, Haage V, et al. Challenges towards serologic diagnostics of emerging arboviruses. Clin Microbiol Infect. 2021. PMID: 34111589. doi:10.1016/j.cmi.2021.05.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。